Publikationen, an denen er mitarbeitet MIGUEL ÁNGEL CALLEJA HERNÁNDEZ (8)

2021

  1. Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis

    Molecular Neurobiology, Vol. 58, Núm. 9, pp. 4716-4726

2020

  1. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis

    Pathology Research and Practice, Vol. 216, Núm. 4

2018

  1. Pharmacogenetic biomarkers of response in Crohn's disease

    Pharmacogenomics Journal, Vol. 18, Núm. 1, pp. 1-13

2017

  1. ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis

    Surgical Oncology, Vol. 26, Núm. 4, pp. 473-482

2016

  1. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients

    Pharmacological Research, Vol. 108, pp. 111-118

  2. Gene polymorphisms as predictors of response to biological therapies in psoriasis patients

    Pharmacological Research, Vol. 113, pp. 71-80

2015

  1. De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer

    Pharmacogenomics, Vol. 16, Núm. 12, pp. 1411-1426

  2. Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer

    Breast Cancer Research and Treatment, Vol. 153, Núm. 3, pp. 493-505